Get 20% lifetime commission for referring investors to digrin.com
here.
Foghorn Therapeutics Inc. ( FHTX) - Stock Earnings
FHTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026 BeforeMarket | — / — | — | — / — | — |
FHTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -21.7 million USD | 9.2 million USD |
| 2026Q1 | -19.9 million USD | 3.3 million USD |
| 2026Q2 | -7.2 million USD | 16.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
FHTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -98.4 million USD | 34.2 million USD |
| 2024 | -86.6 million USD | 22.6 million USD |
| 2025 | -74.3 million USD | 30.9 million USD |
| 2026 Est. | — | — |
FHTX
Price: $6.74
52 week price:
Earnings Per Share: -0.99 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18512
Market Capitalization: 371.8 million